-
Mashup Score: 1Commentary: Global Initiatives to Reduce Cancer Incidence, Mortality Must Tackle Tobacco - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Carolyn Dresler, MD, MPA, and Chris Bostic, JD, say plans to reduce the prevalence and impact of lung cancer must address smoking if they are to succeed.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Majority of NSCLC Patients from Low Socio-Economic Areas in England Do Not Receive Novel Anti-Cancer Therapies - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Despite access to free treatment within the National Health Service, patients in the most deprived areas were 55% less likely to receive targeted therapies, biologic treatments, and immunotherapy compared to residents in the least deprived areas.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023 - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Is “resectability” based on radical resection criteria still valid in the era of neoadjuvant immunochemotherapy? ILCN’s editors say the term needs to be revisited and probably redefined based on a tumor’s status before treatment and after neoadjuvant treatment.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Data Supporting IO Before Surgery in Resectable NSCLC Grows - ILCN.org (ILCN/WCLC) - 11 month(s) ago
During ASCO’s 2023 Annual Meeting investigators shared findings from several neoadjuvant studies, including KEYNOTE-671 and Neotorch, which showed improved EFS with pembrolizumab and toripalimab, respectively.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0From the Editors: Defining Resectability of Non-Small Cell Lung Cancer in 2023 - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Is “resectability” based on radical resection criteria still valid in the era of neoadjuvant immunochemotherapy? ILCN’s editors say the term needs to be revisited and probably redefined based on a tumor’s status before treatment and after neoadjuvant treatment.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0In Brief for May 24, 2023 - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Health Canada gives greenlight to cemiplimab-chemo combo for first-line treatment of advanced NSCLC. Early registration for WCLC 23 ends June 9.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7
Advocacy group says its annual research events are key to its mission: Making EGFR-mutated lung cancer a manageable chronic disease.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Radiation Oncologist Makes Case for Radiotherapy for Local Treatment of Select Patients - ILCN.org (ILCN/WCLC) - 11 month(s) ago
Can radiotherapy replace surgery in stage III NSCLC in the era of immunotherapy? During ELCC 23, Dr. Sara Ramella turned to the data to answer that question.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy - ILCN.org (ILCN/WCLC) - 12 month(s) ago
Presenter Dr. Alex Brunelli says neoadjuvant chemoimmunotherapy is a promising and well-tolerated treatment option in select patients with stage III NSCLC.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Arrhythmias after Radiotherapy—What Do (and Don’t) We Know? - ILCN.org (ILCN/WCLC) - 12 month(s) ago
Researchers examine emerging data demonstrating that functionally distinct arrhythmia classes are associated with radiotherapy dose to discrete cardiac substructures. These observations may help guide potential mitigation efforts for lung cancer patients undergoing radiotherapy.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
New commentary in #ILCN: US plans to reduce the prevalence of #lungcancer will fail if they do not address smoking. https://t.co/8RQUT6DrFx #LCSM